微分脉冲极谱同时测定三种碱性氨基酸的研究

应用微分脉冲极谱，在ｐＨ９．０ ＮａＢ４Ｏ７－ ＣＨ３ＣＨＯ－Ｃｏ２＋－ ＮａＯＨ组成的极谱底液，扫描电位－ ０．８０～－ １．６０ Ｖ、振幅 ２０ｍＶ、扫描速度５ｍＶ／ｓ、一滴汞周期２ｓ的条件下进行连续扫描测量三种碱性氨基酸，获得三个灵敏 度和分辨率均较高的极谱峰图。该法简便快速，稳定可靠，为测量各种蛋白质中的三种磁性氨基酸提供一种新途 径。     

铝镓取代的钨硅杂多配合物位置异构体的合成表征及催化性能

合成了通式为Ｋ５－ｎＨｎ［α－，βｉ－ＳｉＷ１１Ｍ（Ｈ２Ｏ）Ｏ３９］·ｘＨ２Ｏ（Ｍ＝Ａｌ，Ｇａ，βｉ＝β１，β２，β３）的八种异构体。通过元素分析、红外光谱和紫外光谱、极谱和循环伏安、２７Ａｌ和１８３Ｗ核磁共振、Ｘ光电子能谱等方法进行了表征。所合成的各异构体在催化以Ｈ２Ｏ２为氧化剂的顺丁烯二酸环氧化反应中，β３异构体具有最高的催化活性     

筛选免疫药物的单扫描示波极谱法研究

用示波极谱研究了溶血素的溶血活性，在１／１５ｍｏｌＬＮａＨＰＯ４－１．１５ｍｏｌ．ＬＫＨ２ＰＯ（ｐＨ＝７．４）底液中活性溶血素有一灵敏的极谱阴极波，峰电位为－１．８２Ｖ，峰高与溶血素活性在６．０＊１０＾－６－５。３＊１０＾－５ｕｎｉｔ．ｍＬ和５．３＊１０＾－５－２。０＊１０＾－３ｕｎｉｔ／ｍＬ范围内呈线性关系，根据不同药物对抗血清中溶血清形成的不同影响，建立了极谱法筛选免疫药物的新方法。本法简单，     

甘草酸的电化学行为研究

用循环伏安法、单扫描示波极谱法研究了甘草酸（ｇｌｙｃｙｒｒｈｉｚｉｃ，ＧＡ）在汞电极上的电化学行为及反应机理．证明甘草酸在ｐＨ＝４～１２的缓冲溶液（Ｈ３ＢＯ３＋Ｈ３ＰＯ４＋乙酸＋ＮａＯＨ）中有吸附峰，且示波极谱导数峰值与甘草酸浓度在８．３×１０－５～１．２×１０－６ｍｏｌ／Ｌ范围内成正比，使用悬汞电极（ＨＭＤＥ）线性扫描伏安法可使检测下限达２．４×１０－６ｍｏｌ／Ｌ．根据实验结果首次提出了甘草酸在汞电极上的反应机理．该机理同时被紫外光谱证明，得到合理解释     

以Eu^3＋为荧光探针研究（LaO）3BO3的结构

利用多晶Ｘ射线衍射法研究了（ＬａＯ）３ＢＯ３合成的工艺条件和结构。以少量Ｌｉ２ＣＯ３作助熔可在较低温度和较短反应时间内制备出（ＬａＯ３）ＢＯ３纯物相。（ＬａＯ）３ＢＯ３属单斜晶系，空间群为Ｐ２１／ｍ或Ｐ２１。根据Ｅｕ＾３＋荧光光谱以５Ｄ０→７Ｆ２电偶极跃迁为主及５Ｄ０→７ＦＪ（Ｊ＝０、１、２、３、４）跃迁的谱峰数并结合空间群中各个等效点的对称性，推断Ｌａ＾３＋在（ＬａＯ）３ＢＯ３中所处格位的点对称     

测定超氧化物歧化酶活性的一种新的极谱分析方法

报道一种测定超氧化物歧化酶活生的新极谱分析方法，在０．１２５ｍｏｌ／ＬＮＨ３．Ｈ２Ｏ－０．７５ＭＯＬ／ｌ ｎｈ４ｃＬ－２．５％，Ｎａ２ＳＯ３－０．５％，吐温－８０－的介质中，ＳＯＤ在－０．５２Ｖ处产生一氧极谱催化波。ＳＯＤ在１．０×１０＾３Ｕ／Ｌ－４．０×１０＾３Ｕ／Ｌ的活性含量范围内与催化电流呈线性关系，检出限为８．０×１０＾２Ｕ／Ｌ。     

绿原酸的导数极谱法测定

绿原酸的导数极谱法测定李自林郑筱梅（重庆师范学院化学系４０００４７）王琰（重庆建筑大学基础科学系）关键词绿原酸导数极谱法中图分类号Ｏ６５７．１４绿原酸即３－咖啡酰奎宁酸，是咖啡酸和奎宁酸形成的酯。它是金银花的主要成分，具有清热解毒，抗菌消炎的作用。除...     

铋(Ⅲ)-槲皮素极谱络合吸附波及微量铋的测定

在ｐＨ＝３．８，０．４ ｍｏｌ／Ｌ的ＨＣＯＯＨＨＣＯＯＮａ缓冲溶液中，铋与槲皮素的络合物在单扫极谱仪上能形成灵敏的络合物吸附波。该波在Ｂｉ３＋离子浓度为４ × １０－８～６×１０－６ｍｏｌ／Ｌ范围内与波高 ｈｐ成正比关系，检出限达到１×１０－８ｍｏｌ／Ｌ。对电极反应的机理进行了研究。利用该极谱波测定了铅基轴承合金中的铋含量。     

一阶导数差示脉冲极谱法用于扑热息痛的定量分析

一阶导数差示脉冲极谱法用于扑热息痛及其制剂的定量分析，在乙醇－水－２．０×１０＾－＾３ｍｏｌ／ＬＨ２ＳＯ４（１２．５：１１．５：１）的溶液中，于０．２４Ｖ（ｕｓＡｇ／ＡｇＣｌ）处出现良好的一阶导数差示脉冲极谱峰，在３．３×１０＾－＾４～３．３×１０＾－＾３ｍｏｌ／Ｌ范围内，浓度与其一阶导数差示脉冲极谱峰值呈线性关系，检测限为７．８×１０＾－＾８ｍｏｌ／Ｌ。方法简便，快速，灵敏，结果准确。     

3,3‘—四亚甲基—双—（1—苯基—5—吡啶酮—4—羟酸酯）极谱行为研究

ＴＰＰＣ在０．０８ｍｏｌ／ＬＣＨ３ＣＯＯＮａ和０．４ｍｏｌ／ＬＣＨ３ＣＯＯＨ（ＮａＡｃ－ＨＡｃ下同）底液条件下，在电位－１．５７Ｖ附近产生一尖锐的导数波，峰高在３．７×１０＾－６－５．６×１０＾－５ｍｏｌ／Ｌ范围内呈线性关系，同时，讨论了极谱波的性质及电极反应机理。     

高效液相色谱法同时测定双酚伪麻干混悬剂中的盐酸伪麻黄碱和氢溴酸右美沙芬

建立了可同时测定双酚伪麻干混悬剂中盐酸伪麻黄碱和氢溴酸右美沙芬含量的反相高效液相色谱方法。样品先经甲醇溶解,过滤,然后以Lichrospher C6H6化学键合硅胶为固定相、乙腈-水-H3PO4（体积比为50∶50∶0.1,pH 2.5,内含1 g/L十二烷基硫酸钠)为流动相进行色谱分离,在220 nm处定量测定。结果表明,氢溴酸右美沙芬、盐酸伪麻黄碱的质量浓度分别为1.03~206 mg/L和5~200 mg/L时,其峰面积与质量浓度的线性关系良好;批内(n=7)测定的平均相对标准偏差（RSD）分别为1.8%和1.0%,批间(n=5)测定的RSD分别为2.2%和1.5%;对双酚伪麻干混悬剂中氢溴酸右美沙芬、盐酸伪麻黄碱测定回收率分别为100.0%~101.8%和95.7%~98.7%。该法适用于双酚伪麻干混悬剂中氢溴酸右美沙芬和盐酸伪麻黄碱的质量控制及含量测定,方法准确,操作简便。     

微流控芯片非接触电导法测定感冒药中盐酸伪麻黄碱和氢溴酸右美沙芬

研究了用微流控芯片非接触式电导法分离检测感冒药日夜百服咛片中的两种主要成分盐酸伪麻黄碱和氢溴酸右美沙芬的方法。优化条件为:缓冲液20 mmol/L Tris 20 mmol/L H3BO3(pH=8.0);进样电压300 V;进样时间10.0 s;分离电压3.0 kV。非接触电导检测器激发电压60 V(Vp-p),频率60 kHz。两种成分的线性范围分别为20~1000 mg/L和10~1000 mg/L;检出限分别为10和5.0 mg/L;样品回收率分别为99.3%和97.6%。     

High-pressure liquid chromatographic assay of dextromethorphan hydrobromide, guaifenesin, and sodium benzoate in an expectorant syrup

An ion-pair reversed-phase high-pressure liquid chromatographic assay is developed that allows simultaneous quantitation of guaifenesin, dextromethorphan hydrobromide, and sodium benzoate in an expectorant syrup. The method is rapid and accurate. Average recoveries of 99.6, 99.8, and 99.7% with relative standard deviations of 0.5, 0.9, and 0.2% are obtained for guaifenesin, dextromethorphan hydrobromide, and sodium benzoate, respectively, from laboratory prepared samples. Chromatographic conditions are selected to afford a pH that provides adequate separation of guaifenesin, dextromethorphan hydrobromide, sodium benzoate, and sodium saccharin and a detection wavelength that effectively compensates for the great disparity in quantity between guaifenesin and dextromethorphan hydrobromide present in syrups. The relationships between the retention volume of dextromethorphan hydrobromide and the alkyl chain length as well as the concentration of the counterion are studied. The retention profiles for sodium saccharin, guaifenesin, sodium benzoate, and dextromethorphan hydrobromide in the apparent pH range of 2.5 to 6.6 are established.     

A multivariate quantification of Box‐Behnken design assisted method development and validation of dextromethorphan hydrobromide and desloratadine simultaneously by reverse‐phase HPLC in in‐house syrup formulation

An innovative high‐performance liquid chromatography assay method was developed and validated for quantification of dextromethorphan hydrobromide and desloratadine simultaneously in monophasic liquid formulation by preparing syrup containing 30 mg/5 mL of dextromethorphan hydrobromide and 1.2 mg/mL of desloratadine. The chromatographic severance was executed by gradient solution A and B. The composition of buffer solution A contained 0.05 M monobasic potassium, then 1 mL triethylamine was added to it and the pH was adjusted to 2.3 with orthophosphoric acid. Methanol was used as solution B. The gradient elution was executed with Kromasil C8 (250 mm × 4.6 mm) column having 1.5 mL/min flow rate and 20 µL injection volume with UV‐estimation at 254 nm for dextromethorphan hydrobromide and DES. The present research was planned according to Box‐Behnken design by utilizing design expert software, using four factors such as column temperature (A), flow rate (B), mobile phase–organic phase (C), and pH (D); correspondingly the selected response variables were resolution between A and B, that is, desloratadine and methyl paraben (Y1), tailing of dextromethorphan hydrobromide (Y2), and tailing of desloratadine (Y3). The parameters such as system suitability, linearity, accuracy, precision, robustness, limit of detection, limit of quantitation, and ruggedness were analyzed to validate the developed method in accordance with current regulatory guidelines.     

Development and application of spectrophotometric methods for the determination of citalopram hydrobromide in dosage forms

Study was carried out to develop two simple, fast, accurate and sensitive spectrophotometric methods (A and B) for the determination of citalopram hydrobromide in commercial tablet formulations. In method A, UV spectrophotometer determined the contents of citalopram hydrobromide in tablets at 240 nm in methanol solvent. The linear range was 5-40 microg ml-1 with molar absorptivity 1.4x10(4) l mol-1 cm-1. While the method B based on the reaction of citalopram base as n-electron donor with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone as pi-acceptors to give highly colored complex species that absorb maximally at 590 nm. Beer's law was obeyed in the concentration limit of 10-250 microg ml-1 with molar absorptivity 3.3x10(3) l mol-1 cm-1 for citalopram hydrobromide. The limits of detection and limit of quantification was calculated and found to be 5.2 microg ml-1 and 17.4 microg ml-1 respectively. The proposed methods were found to be rapid, accurate, precise and sensitive for the determination of citalopram hydrobromide in commercial tablet formulations with out interferences from common additives encountered.     

Total syntheses of racemic, natural (-) and unnatural (+) glyceollin I

The first total syntheses of racemic glyceollin I and its enantiomers are described. A Wittig approach was utilized as an entry to the appropriately substituted isoflav-3-ene so that an osmium tetroxide mediated asymmetric dihydroxylation could be deployed for stereospecific introduction of the 6a-hydroxy group. While using triphenylphosphine hydrobromide, a novel method was found for gently removing MOM from protected phenolic hydroxyl groups present within sensitive systems.     

Identification and structural elucidation of two process impurities and stress degradants in darifenacin hydrobromide active pharmaceutical ingredient by LC-ESI/MS(n)

The present study describes the identification and characterization of two process impurities and major stress degradants in darifenacin hydrobromide using high performance liquid chromatography (HPLC) analysis. Forced degradation studies confirmed that the drug substance was stable under acidic, alkaline, aqueous hydrolysis, thermal and photolytic conditions and susceptible only to oxidative degradation. Impurities were identified using liquid chromatography coupled with ion trap mass spectrometry (LC-MS/MS(n)). Proposed structures were unambiguously confirmed by synthesis followed by characterization using nuclear magnetic resonance spectroscopy (NMR), infrared spectroscopy (IR) and elemental analysis (EA). Based on the spectroscopic, spectrometric and elemental analysis data, the unknown impurities were characterized as 2-{1-[2-(2,3-dihydrobenzofuran-5-yl)-2-oxo-ethyl]-pyrrolidin-3-yl}-2,2-diphenylacetamide (Imp-A), 2-[1-(2-benzofuran-5-yl-ethyl)-pyrrolidin-3-yl]-2,2-diphenylacetamide (Imp-B), 2-{1-[2-(2,3-dihydrobenzofuran-5-yl)-ethyl]-1-oxy-pyrrolidin-3-yl}-2,2-diphenylacetamide (Imp-C) and 2-{1-[2-(7-bromo-2,3-dihydrobenzofuran-5-yl)-ethyl]-pyrrolidin-3-yl}-2,2-diphenylacetamide (Imp-D). Plausible mechanisms for the formation and control of these impurities have also been proposed. The method was validated as per regulatory guidelines to demonstrate specificity, sensitivity, linearity, precision, accuracy and the stability-indicating nature. Regression analysis showed a correlation coefficient value greater than 0.99 for darifenacin hydrobromide and its impurities. The accuracy of the method was established based on the recovery obtained between 86.6 and 106.7% for all impurities.     

Simultaneous determination of six toxic alkaloids in human plasma and urine using capillary zone electrophoresis coupled to time‐of‐flight mass spectrometry

A novel capillary zone electrophoresis separation coupled to electro spray ionization time‐of‐flight mass spectrometry method was developed for the simultaneous analysis of six toxic alkaloids: brucine, strychnine, atropine sulfate, anisodamine hydrobromide, scopolamine hydrobromide and anisodine hydrobromide in human plasma and urine. To obtain optimal sensitivity, a solid‐phase extraction method using Oasis MCX cartridges (1 mL, 30 mg; Waters, USA) for the pretreatment of samples was used. All compounds were separated by capillary zone electrophoresis at 25 kV within 12 min in an uncoated fused‐silica capillary of 75 μm id × 100 cm and were detected by time‐of‐flight mass spectrometry. This method was validated with regard to precision, accuracy, sensitivity, linear range, limit of detection (LOD), and limit of quantification (LOQ). In the plasma and urine samples, the linear calibration curves were obtained over the range of 0.50–100 ng/mL. The LOD and LOQ were 0.2–0.5 ng/mL and 0.5–1.0 ng/mL, respectively. The intra‐ and interday precision was better than 12% and 13%, respectively. Electrophoretic peaks could be identified by mass analysis.     

Synthesis of fused indazole ring systems and application to nigeglanine hydrobromide

The single-step synthesis of fused tricyclic pyridazino[1,2-a]indazolium ring systems is described. Structural details revealed by crystallography explain the unexpected reactivity. The method is applied to the gram scale synthesis of nigeglanine hydrobromide.     

The intramolecular beta-fluorine...ammonium interaction in 4- and 8-membered rings

The structures of 3-fluoroazetidinium hydrochloride and 3-fluoro-1,5-diazacyclooctane hydrobromide are explored both by X-ray diffraction analysis and DFT calculations, and the conformations of these molecules are shown to be significantly influenced by the through space C-F...N+ interaction.